149 related articles for article (PubMed ID: 15451024)
1. Role of specific protein kinase C isoforms in modulation of beta1- and beta2-adrenergic receptors.
Guimond J; Mamarbachi AM; Allen BG; Rindt H; Hébert TE
Cell Signal; 2005 Jan; 17(1):49-58. PubMed ID: 15451024
[TBL] [Abstract][Full Text] [Related]
2. Cardiac-specific overexpression of alpha1BAR regulates betaAR activity via molecular crosstalk.
Lemire I; Allen BG; Rindt H; Hebert TE
J Mol Cell Cardiol; 1998 Sep; 30(9):1827-39. PubMed ID: 9769238
[TBL] [Abstract][Full Text] [Related]
3. Distinct receptor domains determine subtype-specific coupling and desensitization phenotypes for human beta1- and beta2-adrenergic receptors.
Rousseau G; Nantel F; Bouvier M
Mol Pharmacol; 1996 Apr; 49(4):752-60. PubMed ID: 8609905
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of alveolar epithelial active Na+ transport is dependent on beta2-adrenergic receptor signaling.
Mutlu GM; Dumasius V; Burhop J; McShane PJ; Meng FJ; Welch L; Dumasius A; Mohebahmadi N; Thakuria G; Hardiman K; Matalon S; Hollenberg S; Factor P
Circ Res; 2004 Apr; 94(8):1091-100. PubMed ID: 15016730
[TBL] [Abstract][Full Text] [Related]
5. Histamine H2 receptor mediated dual signaling: mapping of structural requirements using beta2 adrenergic chimeric receptors.
Wang LD; Gantz I; Butler K; Hoeltzel M; Del Valle J
Biochem Biophys Res Commun; 2000 Sep; 276(2):539-45. PubMed ID: 11027510
[TBL] [Abstract][Full Text] [Related]
6. Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies.
Tran TM; Friedman J; Qunaibi E; Baameur F; Moore RH; Clark RB
Mol Pharmacol; 2004 Jan; 65(1):196-206. PubMed ID: 14722251
[TBL] [Abstract][Full Text] [Related]
7. Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins.
Xiao RP
Sci STKE; 2001 Oct; 2001(104):re15. PubMed ID: 11604549
[TBL] [Abstract][Full Text] [Related]
8. Heterodimerization of beta1- and beta2-adrenergic receptor subtypes optimizes beta-adrenergic modulation of cardiac contractility.
Zhu WZ; Chakir K; Zhang S; Yang D; Lavoie C; Bouvier M; Hébert TE; Lakatta EG; Cheng H; Xiao RP
Circ Res; 2005 Aug; 97(3):244-51. PubMed ID: 16002745
[TBL] [Abstract][Full Text] [Related]
9. Distinct beta-adrenergic receptor subtype signaling in the heart and their pathophysiological relevance.
Zheng M; Han QD; Xiao RP
Sheng Li Xue Bao; 2004 Feb; 56(1):1-15. PubMed ID: 14985822
[TBL] [Abstract][Full Text] [Related]
10. Functional receptor coupling to Gi is a mechanism of agonist-promoted desensitization of the beta2-adrenergic receptor.
Tepe NM; Liggett SB
J Recept Signal Transduct Res; 2000 Jan; 20(1):75-85. PubMed ID: 10711498
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase C and epidermal growth factor stimulation of Raf1 potentiates adenylyl cyclase type 6 activation in intact cells.
Beazely MA; Alan JK; Watts VJ
Mol Pharmacol; 2005 Jan; 67(1):250-9. PubMed ID: 15470083
[TBL] [Abstract][Full Text] [Related]
12. Sustained beta1-adrenergic stimulation modulates cardiac contractility by Ca2+/calmodulin kinase signaling pathway.
Wang W; Zhu W; Wang S; Yang D; Crow MT; Xiao RP; Cheng H
Circ Res; 2004 Oct; 95(8):798-806. PubMed ID: 15375008
[TBL] [Abstract][Full Text] [Related]
13. Heterologous desensitization of cardiac β-adrenergic signal via hormone-induced βAR/arrestin/PDE4 complexes.
Shi Q; Li M; Mika D; Fu Q; Kim S; Phan J; Shen A; Vandecasteele G; Xiang YK
Cardiovasc Res; 2017 May; 113(6):656-670. PubMed ID: 28339772
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of putative beta1-beta2-adrenergic receptor heterodimers.
Lavoie C; Hébert TE
Can J Physiol Pharmacol; 2003 Feb; 81(2):186-95. PubMed ID: 12710533
[TBL] [Abstract][Full Text] [Related]
15. Mediation of corticotropin releasing factor type 1 receptor phosphorylation and desensitization by protein kinase C: a possible role in stress adaptation.
Hauger RL; Olivares-Reyes JA; Braun S; Catt KJ; Dautzenberg FM
J Pharmacol Exp Ther; 2003 Aug; 306(2):794-803. PubMed ID: 12734388
[TBL] [Abstract][Full Text] [Related]
16. Cellular characterization of the pharmacological selectivity and tachyphylactic properties of denopamine for the human beta adrenergic receptors.
Suzuki T; Nantel F; Bonin H; Valiquette M; Bouvier M
J Pharmacol Exp Ther; 1993 Nov; 267(2):785-90. PubMed ID: 7902433
[TBL] [Abstract][Full Text] [Related]
17. Beta 2-adrenergic receptor mutants reveal structural requirements for the desensitization observed with long-term epinephrine treatment.
Proll MA; Clark RB; Butcher RW
Mol Pharmacol; 1993 Sep; 44(3):569-74. PubMed ID: 8396717
[TBL] [Abstract][Full Text] [Related]
18. Partial rescue of functional interactions of a nonpalmitoylated mutant of the G-protein G alpha s by fusion to the beta-adrenergic receptor.
Ugur O; Onaran HO; Jones TL
Biochemistry; 2003 Mar; 42(9):2607-15. PubMed ID: 12614155
[TBL] [Abstract][Full Text] [Related]
19. Adenylyl cyclase type V deletion increases basal left ventricular function and reduces left ventricular contractile responsiveness to beta-adrenergic stimulation.
Tang T; Lai NC; Roth DM; Drumm J; Guo T; Lee KW; Han PL; Dalton N; Gao MH
Basic Res Cardiol; 2006 Mar; 101(2):117-26. PubMed ID: 16283593
[TBL] [Abstract][Full Text] [Related]
20. Beta1 adrenergic receptor-mediated enhancement of hippocampal CA3 network activity.
Jurgens CW; Rau KE; Knudson CA; King JD; Carr PA; Porter JE; Doze VA
J Pharmacol Exp Ther; 2005 Aug; 314(2):552-60. PubMed ID: 15908512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
